U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Hereditary clear cell renal cell carcinoma

MedGen UID:
234343
•Concept ID:
C1333985
•
Neoplastic Process
Synonyms: hereditary clear cell renal carcinoma; Hereditary clear cell renal cell adenocarcinoma; hereditary clear cell renal cell adenocarcinoma; Hereditary clear cell renal cell cancer; Hereditary Clear Cell Renal Cell Carcinoma; hereditary clear cell renal cell carcinoma; Hereditary Conventional (Clear Cell) Renal Cell Carcinoma; hereditary conventional (clear cell) renal cell carcinoma; hereditary conventional renal cell carcinoma; Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma
SNOMED CT: Hereditary clear cell renal cell carcinoma (764961009); Hereditary clear cell renal cell adenocarcinoma (764961009)
Modes of inheritance:
Unknown inheritance
MedGen UID:
989040
•Concept ID:
CN307042
•
Finding
Source: Orphanet
Hereditary clinical entity whose mode of inheritance is unknown.
See: This record
Unknown inheritance (Orphanet)
 
Monarch Initiative: MONDO:0018492
Orphanet: ORPHA422526

Definition

A hereditary renal cancer syndrome defined as development of hereditary clear cell renal cell carcinoma (ccRCC) in two or more family members without evidence of constitutional chromosome 3 translocation, von Hippel-Lindau disease or other neoplasm predisposing syndromes associated with ccRCC, such as tuberous sclerosis or Birt-Hogg-Dubbe syndrome. [from SNOMEDCT_US]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVHereditary clear cell renal cell carcinoma

Professional guidelines

PubMed

Telomere-related gene risk model for prognosis and drug treatment efficiency prediction in kidney cancer.
Li SC, Jia ZK, Yang JJ, Ning XH
Front Immunol 2022;13:975057. Epub 2022 Sep 16 doi: 10.3389/fimmu.2022.975057. PMID: 36189312Free PMC Article
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Gill AJ
Mod Pathol 2021 Jul;34(7):1392-1424. Epub 2021 Mar 4 doi: 10.1038/s41379-021-00779-w. PMID: 33664427
Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
Maher ER
World J Urol 2018 Dec;36(12):1891-1898. Epub 2018 Apr 21 doi: 10.1007/s00345-018-2288-5. PMID: 29680948Free PMC Article

Recent clinical studies

Etiology

von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance.
Louise M Binderup M, Smerdel M, Borgwadt L, Beck Nielsen SS, Madsen MG, Møller HU, Kiilgaard JF, Friis-Hansen L, Harbud V, Cortnum S, Owen H, Gimsing S, Friis Juhl HA, Munthe S, Geilswijk M, Rasmussen ÅK, Møldrup U, Graumann O, Donskov F, Grønbæk H, Stausbøl-Grøn B, Schaffalitzky de Muckadell O, Knigge U, Dam G, Wadt KA, Bøgeskov L, Bagi P, Lund L, Stochholm K, Ousager LB, Sunde L
Eur J Med Genet 2022 Aug;65(8):104538. Epub 2022 Jun 13 doi: 10.1016/j.ejmg.2022.104538. PMID: 35709961
BAP1: Not just a BRCA1-associated protein.
Louie BH, Kurzrock R
Cancer Treat Rev 2020 Nov;90:102091. Epub 2020 Aug 20 doi: 10.1016/j.ctrv.2020.102091. PMID: 32877777Free PMC Article
Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
Maher ER
World J Urol 2018 Dec;36(12):1891-1898. Epub 2018 Apr 21 doi: 10.1007/s00345-018-2288-5. PMID: 29680948Free PMC Article
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM
Eur Urol 2016 Jul;70(1):93-105. Epub 2016 Feb 28 doi: 10.1016/j.eururo.2016.02.029. PMID: 26935559
Renal cell carcinoma: Review of etiology, pathophysiology and risk factors.
Petejova N, Martinek A
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2016 Jun;160(2):183-94. Epub 2015 Nov 3 doi: 10.5507/bp.2015.050. PMID: 26558360

Diagnosis

von Hippel-Lindau disease: Updated guideline for diagnosis and surveillance.
Louise M Binderup M, Smerdel M, Borgwadt L, Beck Nielsen SS, Madsen MG, Møller HU, Kiilgaard JF, Friis-Hansen L, Harbud V, Cortnum S, Owen H, Gimsing S, Friis Juhl HA, Munthe S, Geilswijk M, Rasmussen ÅK, Møldrup U, Graumann O, Donskov F, Grønbæk H, Stausbøl-Grøn B, Schaffalitzky de Muckadell O, Knigge U, Dam G, Wadt KA, Bøgeskov L, Bagi P, Lund L, Stochholm K, Ousager LB, Sunde L
Eur J Med Genet 2022 Aug;65(8):104538. Epub 2022 Jun 13 doi: 10.1016/j.ejmg.2022.104538. PMID: 35709961
Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research.
Ooi A
Semin Cancer Biol 2020 Apr;61:158-166. Epub 2019 Nov 2 doi: 10.1016/j.semcancer.2019.10.016. PMID: 31689495Free PMC Article
Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
Maher ER
World J Urol 2018 Dec;36(12):1891-1898. Epub 2018 Apr 21 doi: 10.1007/s00345-018-2288-5. PMID: 29680948Free PMC Article
Renal cell carcinoma: Review of etiology, pathophysiology and risk factors.
Petejova N, Martinek A
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2016 Jun;160(2):183-94. Epub 2015 Nov 3 doi: 10.5507/bp.2015.050. PMID: 26558360
Von Hippel-Lindau Syndrome.
Ben-Skowronek I, Kozaczuk S
Horm Res Paediatr 2015;84(3):145-52. Epub 2015 Aug 5 doi: 10.1159/000431323. PMID: 26279462

Therapy

JAK2 unmutated erythrocytosis: 2023 Update on diagnosis and management.
Gangat N, Szuber N, Tefferi A
Am J Hematol 2023 Jun;98(6):965-981. Epub 2023 Apr 3 doi: 10.1002/ajh.26920. PMID: 36966432
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.
Ligon JA, Sundby RT, Wedekind MF, Arnaldez FI, Del Rivero J, Wiener L, Srinivasan R, Spencer M, Carbonell A, Lei H, Shern J, Steinberg SM, Figg WD, Peer CJ, Zimmerman S, Moraly J, Xu X, Fox S, Chan K, Barbato MI, Andresson T, Taylor N, Pacak K, Killian JK, Dombi E, Linehan WM, Miettinen M, Piekarz R, Helman LJ, Meltzer P, Widemann B, Glod J
Clin Cancer Res 2023 Jan 17;29(2):341-348. doi: 10.1158/1078-0432.CCR-22-2168. PMID: 36302175Free PMC Article
Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma.
Xu Y, Kong W, Cao M, Wang J, Wang Z, Zheng L, Wu X, Cheng R, He W, Yang B, Dong B, Pan J, Chen Y, Huang J, Jiang C, Zhai W, Li F, Chen R, Zhou X, Wu G, Geng X, Chen J, An H, Yuan Y, Xu T, Chen D, Lin D, Xu L, Huang K, Peng L, Yu Y, Tai S, Qi H, Luo K, Kang X, Wang H, Huang Y, Zhang J, Xue W
Eur Urol 2023 Feb;83(2):163-172. Epub 2022 Jun 15 doi: 10.1016/j.eururo.2022.05.029. PMID: 35715365
Renal cell carcinoma: Review of etiology, pathophysiology and risk factors.
Petejova N, Martinek A
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2016 Jun;160(2):183-94. Epub 2015 Nov 3 doi: 10.5507/bp.2015.050. PMID: 26558360
Renal cell carcinoma.
Rini BI, Campbell SC, Rathmell WK
Curr Opin Oncol 2006 May;18(3):289-96. doi: 10.1097/01.cco.0000219260.60714.c4. PMID: 16552243

Prognosis

Telomere-related gene risk model for prognosis and drug treatment efficiency prediction in kidney cancer.
Li SC, Jia ZK, Yang JJ, Ning XH
Front Immunol 2022;13:975057. Epub 2022 Sep 16 doi: 10.3389/fimmu.2022.975057. PMID: 36189312Free PMC Article
Hereditary leiomyomatosis and renal cell cancer (HLRCC): Case series and review of the literature.
Yu Y, Zheng M, Zhu W, Zhao F, Guan B, Shen Q, Yang F, He Q, Li X
Urol Oncol 2021 Nov;39(11):791.e9-791.e16. Epub 2021 Aug 27 doi: 10.1016/j.urolonc.2021.07.026. PMID: 34462205
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Gill AJ
Mod Pathol 2021 Jul;34(7):1392-1424. Epub 2021 Mar 4 doi: 10.1038/s41379-021-00779-w. PMID: 33664427
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Hes O
Mod Pathol 2021 Jun;34(6):1167-1184. Epub 2021 Feb 1 doi: 10.1038/s41379-021-00737-6. PMID: 33526874
Von Hippel-Lindau Syndrome.
Ben-Skowronek I, Kozaczuk S
Horm Res Paediatr 2015;84(3):145-52. Epub 2015 Aug 5 doi: 10.1159/000431323. PMID: 26279462

Clinical prediction guides

Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma.
Xu Y, Kong W, Cao M, Wang J, Wang Z, Zheng L, Wu X, Cheng R, He W, Yang B, Dong B, Pan J, Chen Y, Huang J, Jiang C, Zhai W, Li F, Chen R, Zhou X, Wu G, Geng X, Chen J, An H, Yuan Y, Xu T, Chen D, Lin D, Xu L, Huang K, Peng L, Yu Y, Tai S, Qi H, Luo K, Kang X, Wang H, Huang Y, Zhang J, Xue W
Eur Urol 2023 Feb;83(2):163-172. Epub 2022 Jun 15 doi: 10.1016/j.eururo.2022.05.029. PMID: 35715365
Telomere-related gene risk model for prognosis and drug treatment efficiency prediction in kidney cancer.
Li SC, Jia ZK, Yang JJ, Ning XH
Front Immunol 2022;13:975057. Epub 2022 Sep 16 doi: 10.3389/fimmu.2022.975057. PMID: 36189312Free PMC Article
Claudin-10 overexpression suppresses human clear cell renal cell carcinoma growth and metastasis by regulating ATP5O and causing mitochondrial dysfunction.
Yang W, Zhang K, Zhang Z, Zhou J, Li L, Xu Y, Qiu J, Cai L, Gong Y, Gong K
Int J Biol Sci 2022;18(6):2329-2344. Epub 2022 Mar 6 doi: 10.7150/ijbs.70105. PMID: 35414767Free PMC Article
Hereditary leiomyomatosis and renal cell cancer (HLRCC): Case series and review of the literature.
Yu Y, Zheng M, Zhu W, Zhao F, Guan B, Shen Q, Yang F, He Q, Li X
Urol Oncol 2021 Nov;39(11):791.e9-791.e16. Epub 2021 Aug 27 doi: 10.1016/j.urolonc.2021.07.026. PMID: 34462205
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.
Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Gill AJ
Mod Pathol 2021 Jul;34(7):1392-1424. Epub 2021 Mar 4 doi: 10.1038/s41379-021-00779-w. PMID: 33664427

Recent systematic reviews

Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature.
Hassler MR, Bray F, Catto JWF, Grollman AP, Hartmann A, Margulis V, Matin SF, Roupret M, Sfakianos JP, Shariat SF, Faltas BM
Eur Urol 2020 Aug;78(2):209-220. Epub 2020 Jun 20 doi: 10.1016/j.eururo.2020.05.039. PMID: 32571725
Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights.
Carlo MI, Hakimi AA, Stewart GD, Bratslavsky G, Brugarolas J, Chen YB, Linehan WM, Maher ER, Merino MJ, Offit K, Reuter VE, Shuch B, Coleman JA
Eur Urol 2019 Dec;76(6):754-764. Epub 2019 Jul 18 doi: 10.1016/j.eururo.2019.06.015. PMID: 31326218Free PMC Article
Hereditary renal cancer syndromes: an update of a systematic review.
Verine J, Pluvinage A, Bousquet G, Lehmann-Che J, de Bazelaire C, Soufir N, Mongiat-Artus P
Eur Urol 2010 Nov;58(5):701-10. Epub 2010 Aug 27 doi: 10.1016/j.eururo.2010.08.031. PMID: 20817385
Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy.
Pfaffenroth EC, Linehan WM
Expert Opin Biol Ther 2008 Jun;8(6):779-90. doi: 10.1517/14712598.8.6.779. PMID: 18476789Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...